US BIOTECH firm Moderna Inc says preliminary data from a continuing phase three study of its experimental COVID-19 vaccine showed it to be 94.5 percent effective,...
US BIOTECH firm Moderna Inc says preliminary data from a continuing phase three study of its experimental COVID-19 vaccine showed it to be 94.5 percent effective,...